EXPERIMENTAL OPHTHALMOLOGY
Software Workflow for Proteomics Profiling studies:
.gif)
Targeting glial fibrillary acidic protein in glaucoma: a monoclonal antibody approach to modulate...
Correlation of Functional and Structural Outcomes with Serum Antibody Profiles in Patients with...
Lab Hero Award 2023 Dr. Caroline Manicam is Winner of the Lab Leader category from a total of 160...
Adaptive responses of neuronal cells to chronic endoplasmic reticulum (ER) stress. Pham TNM,...
EVER AWARD The Scientific Committee of EVER 2023 awarded Dr. Caroline Manicam for the Best Poster...
EVER AWARD The Scientific Committee of EVER 2023 awarded Dr. Natarajan Perumal for the Best Poster...
Glaucoma Research Award 2023 Jeff Kristian Nzogang Fomo, MSc. was awarded from the Scientific...
Our unit can offer a basic research fellowship at the Dept. of Ophthalmology in Mainz.
We can provide state of the art facilities for biochemical and immunological research projects.
The fellow has to develop in-depth interests in one of our research projects esp. in glaucoma and tearfilm. Please visit the sections of our web-site, which describe our current research projects in detail.
We can offer all methods that are necessary to perform the projects such as electrophoretical techniques, Western blotting, protein profiling on ProteinChips (Seldi-TOF), identification of proteins of interest by MALDI-TOF and Maldi-TOFTOF, fractionation of proteins by Nano-LC and robotic station, membrane spotting, characterisation of cells by FACS, etc.
A minimum 12 months committment is required. If you are interested in our research program, please send a curriculum vitae and two reference letters.
All of our funded basic science training posts are currently occupied. When they will become available, they will be advertised in this web-site and in international journals.
However, there are always options for self-funded visiting researchers to work in our research projects and for those who are interested in our technology and bioinformatic developments.
If you think you may fit into this category, please send an E-mail with your curriculum vitae and your scientific goals.
Our experimental and clinical projects are funded by different souces e.g.:
For recent information check our News section.
Glaucomatous optic neuropathy is a chronic process over many years which finally leads to apoptosis with a loss of retinal ganglion cells associated with the loss of visual function.
Several mechanisms such as Glutamate induced excitotoxicity, generation of free radicals and NO neurotoxicity that could be responsible for retinal ganglia cell death were discussed.
The treatment with neuroprotective agents with various structures and different mechanisms of action could provide protection to the remaining neurons.
The aim of this research area is to investigate the effect of different neuroprotective agents on apoptotic retinal ganglia cells.
Therefore, apoptose tests, FACS, and protein profiling will be performed.
In cooperation with the Institute of Pharmacy (PD Dr. U. Ulbrich PhD) and pharmaceutical companies we have large ongoing studies on the apoptosis and proteome profiles of retinal ganglion cells in order to test the neuroprotective power of several different drugs.
If there is an autoimmune component in glaucoma, an immunomodulating treatment could be benificial. Therefore, new immunomodulating drugs are needed. In previous studies, we could demonstrate that allopurinol can change the auto-antibody and cytokine profiles in different animal models. We could show that allopurinol is effective in the treatment of lens-induced uveitis (LIU), and experimental autoimmune uveitis (EAU).